about
M2e-Based Universal Influenza A VaccinesAllergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseasesIntranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.Dose imprecision and resistance: free-choice medicated feeds in industrial food animal production in the United States.Innate Immune Signaling by, and Genetic Adjuvants for DNA VaccinationFormulation and delivery of vaccines: Ongoing challenges for animal management.DNA immunization.Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines.DNA vaccines for targeting bacterial infections.The strategic use of novel smallpox vaccines in the post-eradication world.Strategies and hurdles using DNA vaccines to fish.Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice.CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses.A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting.ImmunoassaySelection by RNA-RNA Interaction: Maximally Minimized Antibiotic Resistance-Free Plasmids
P2860
Q26783493-B27A8900-FFC0-4C8F-BA0A-1BFB15340B16Q26828969-FE3AB9B0-9533-4CB5-A942-896503F1B5D2Q34309830-F67D7F1A-753F-4EE6-BB40-BB801C1C5E12Q34606356-F88C110D-745D-48FF-92A7-E9061AA95699Q34691942-013110FF-07E6-4CED-9E38-A6424AB118D8Q35826673-2DC971EB-278E-4CD0-B13C-9F43D4AB1436Q36470265-0F3E3C83-C30F-48E4-9C16-9A4DB8B68040Q37576264-55EA6480-F8C7-4B36-A5C5-6F991916CCD6Q37676195-FC6A4CE0-2580-49EF-9EE0-3B713F5CA5BCQ37771943-8B59B15A-2EF9-4C98-9B26-B66EC8319DCEQ37909421-BAE06420-01E8-49E3-A116-3BB2EED2833CQ38189450-C362A650-998C-4243-892E-2B327FAC1238Q47873692-DE394F0A-71F8-458E-9044-B010D045B400Q48142387-AB84ACC4-5C53-4E74-9102-50C08E46ACAFQ54942043-29D5F741-A8C6-4585-BE23-5B3916E2978FQ58440224-6B0D461B-4FA1-4CA1-B525-5FDB68C88C13Q58840785-771446C2-C81E-48D5-A941-6F57FE4D3E6E
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
DNA vaccines in veterinary use.
@ast
DNA vaccines in veterinary use.
@en
type
label
DNA vaccines in veterinary use.
@ast
DNA vaccines in veterinary use.
@en
prefLabel
DNA vaccines in veterinary use.
@ast
DNA vaccines in veterinary use.
@en
P2860
P356
P1476
DNA vaccines in veterinary use.
@en
P2093
David B Weiner
Laurel Redding
P2860
P304
P356
10.1586/ERV.09.77
P577
2009-09-01T00:00:00Z